Key Advisors

AKLRD’s business model is led by a small group of executives accessing expert opinion to guide corporate strategy and product development.

These key advisors are recognised experts in their field and used extensively to guide AKLRD’s corporate, preclinical and clinical strategy.

Strategy:
Dr. Annalisa Jenkins
Former Executive VP and Global Head Research & Development Merck Serono, SVP and Head of Global Medical Affairs BMS

Nigel Brooksby
Former Chairman and MD of Sanofi UK, Nigel holds several Academic, Charity and Life Sciences Chairmanships and Senior Board positions

Lord Grade CBE
Trustee of the Science Museum Group, former Executive Chairman ITV, Chairman of the BBC, CEO Channel 4

Preclinical:
Prof. Frank Bonner
Former Director of Science & Technology, Huntingdon Life Sciences. Former President of British Toxicology Society

Manufacturing:
John McCrerie
Former Technical Director of Becpharm Limited; Senior Manager and International QA Director Wellcome Glaxo

AKL4 (aka APPA) Collaborators:
Dr Andy Cross
University of Liverpool, Research Associate Musculoskeletal Biology